Author:
Senapati Jayastu,Kantarjian Hagop,Haddad Fadi G.,Short Nicholas J.,Welch Mary Alma,Jain Nitin,Jabbour Elias
Reference82 articles.
1. Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017;Sasaki;Am J Hematol,2021
2. The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades;Jabbour;J Hematol Oncol,2023
3. Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms;Short;Leukemia,2021
4. Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past;Short;Lancet Haematol,2023
5. Bassan R, Chiaretti S, Starza ID, et al. Preliminary results of the GIMEMA LAL2317 sequential chemotherapy-blinatumomab front-line trial for newly diagnosed adult Ph-negative B-lineage ALL patients. European Hematology Association. Abstract S114. Presented June 9, 2021.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献